Conversely, patients with minimal weight loss may experience smaller changes in cholesterol, though direct GLP-1 signaling effects on the liver can still produce modest lipid gains
Haase CL, Serratore Achenbach MG, Lucrezi G, Jeswani N, Maurer S, Egermann U
This may include your BMI, weight-related health conditions, and a history of previous weight loss attempts
The absorption curve does not plateau instantly after 2 minutes
Other studies show that Cotaduide could intervene and reverse NASH through improving metabolism in the liver including lipid and glucose metabolism via GCGR in mice, suggesting that Cotaduide may be a potential and viable therapeutic as a targeted drug intervention to reverse disease progression of NASH (131)